Extracellular vesicles remodel tumor environment for cancer immunotherapy
Top Cited Papers
Open Access
- 13 December 2023
- journal article
- review article
- Published by Springer Nature in Molecular Cancer
- Vol. 22 (1) , 1-20
Abstract
Tumor immunotherapy has transformed neoplastic disease management, yet low response rates and immune complications persist as major challenges. Extracellular vesicles including exosomes have emerged as therapeutic agents actively involved in a diverse range of pathological conditions. Mounting evidence suggests that alterations in the quantity and composition of extracellular vesicles (EVs) contribute to the remodeling of the immune-suppressive tumor microenvironment (TME), thereby influencing the efficacy of immunotherapy. This revelation has sparked clinical interest in utilizing EVs for immune sensitization. In this perspective article, we present a comprehensive overview of the origins, generation, and interplay among various components of EVs within the TME. Furthermore, we discuss the pivotal role of EVs in reshaping the TME during tumorigenesis and their specific cargo, such as PD-1 and non-coding RNA, which influence the phenotypes of critical immune cells within the TME. Additionally, we summarize the applications of EVs in different anti-tumor therapies, the latest advancements in engineering EVs for cancer immunotherapy, and the challenges encountered in clinical translation. In light of these findings, we advocate for a broader understanding of the impact of EVs on the TME, as this will unveil overlooked therapeutic vulnerabilities and potentially enhance the efficacy of existing cancer immunotherapies.Keywords
Funding Information
- National Natural Science Foundation of China (81972663)
- Scientific Research and Innovation Team of the First Affiliated Hospital of Zhengzhou University (ZYCXTD2023018)
- The Excellent Youth Science Project of Henan Natural Science Foundation (212300410074)
- The Youth Talent Innovation Team Support Program of Zhengzhou University (32320290)
- The Provincial and Ministry co-constructed key projects of Henan medical science and technology (SBGJ202102134)
- Henan Medical Technology Popularization Project (SYJS2022109)
- Henan Provincial Health and Health Commission Joint Construction Project (LHGJ20200158)
- Henan Province young and middle-aged health science and technology innovation leading talent project (YXKC2022016)
This publication has 214 references indexed in Scilit:
- Contribution of proteomics to understanding the role of tumor‐derived exosomes in cancer progression: State of the art and new perspectivesProteomics, 2013
- Nanoparticle tracking analysis monitors microvesicle and exosome secretion from immune cellsImmunology, 2012
- Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking AnalysisNanomedicine: Nanotechnology, Biology and Medicine, 2011
- Non-coding RNAs in human diseaseNature Reviews Genetics, 2011
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate CancerNew England Journal of Medicine, 2010
- Membrane vesicles as conveyors of immune responsesNature Reviews Immunology, 2009
- The metastatic niche: adapting the foreign soilNature Reviews Cancer, 2009
- Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cellsNature Cell Biology, 2007
- VEGF-C–induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sitesBlood, 2006
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001